Stipulation of the Possibility to Use Embryonic Neuronal Cells when Treating Organospecific Autoimmune Diseases
Keywords:, transplantation of embryonic neuronal cells, cryopreservation, allergic encephalomyelitis
There was studied the possibility of this pathology treatment with intraperitoneal introduction of native and cryopreserved embryonic neuronal cells (ENCs) in the model of allergic encephalomyelitis as experimental analogue of multiple sclerosis (MS). The efficiency of performed therapy is established to be determined both by morphofunctional status of transplants and their introduction terms, i.e. to the 7thÂ and 14thÂ day of the pathological process development. It has been noted that cryopreserved ENCs (cENCs) in contrast to native ENCs (nENCs) during the introduction had correction peculiarities of clinical and neurological status of animals, immune regulatory index, killer activity of splenocytes and content of finely dispersed circulating immune complexes (fCIC) in blood serum.
How to Cite
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).